• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪凝血因子VIII的cDNA及推导的氨基酸序列。

The cDNA and derived amino acid sequence of porcine factor VIII.

作者信息

Healey J F, Lubin I M, Lollar P

机构信息

Department of Medicine, Emory University, Atlanta GA 30322, USA.

出版信息

Blood. 1996 Dec 1;88(11):4209-14.

PMID:8943856
Abstract

The cDNA corresponding to 137 bp of the 5' untranslated region, the signal peptide, and the A1, A3, C1, and C2 domains of porcine factor VIII (fVIII) have been cloned and sequenced. Along with previously determined sequences of the porcine fVIII B domain and the A2 domain, this completes the sequence determination of the cDNA corresponding to the translated protein. Alignments of the derived amino acid sequence of porcine fVIII with human and murine fVIII indicate that the A1, A2, A3, C1, and C2 domains are more conserved than the B domains or the proteolytic cleavage peptides corresponding to residues 337-372 and 1649-1689. The knowledge of the porcine fVIII cDNA may be useful to understand functional and immunological differences between human and porcine fVIII and may lead to improved fVIII replacement products for hemophilia. A patients through the development of recombinant porcine fVIII or hybrid human/porcine fVIII derivatives.

摘要

已克隆并测序了与猪因子VIII(fVIII)5'非翻译区137 bp、信号肽以及A1、A3、C1和C2结构域相对应的cDNA。连同先前确定的猪fVIII B结构域和A2结构域的序列,这完成了与翻译后蛋白质相对应的cDNA的序列测定。猪fVIII推导的氨基酸序列与人及小鼠fVIII的比对表明,A1、A2、A3、C1和C2结构域比B结构域或对应于337 - 372位和1649 - 1689位残基的蛋白水解切割肽更保守。猪fVIII cDNA的知识可能有助于理解人fVIII和猪fVIII之间的功能和免疫学差异,并可能通过开发重组猪fVIII或人/猪fVIII杂交衍生物为血友病A患者带来改良的fVIII替代产品。

相似文献

1
The cDNA and derived amino acid sequence of porcine factor VIII.猪凝血因子VIII的cDNA及推导的氨基酸序列。
Blood. 1996 Dec 1;88(11):4209-14.
2
Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.使用多重取代的人/猪杂交因子VIII分子降低因子VIII对复合抑制性抗体血浆的抗原性。
Blood. 2000 Jan 15;95(2):564-8.
3
Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.识别人类凝血因子 VIII 重链中 A2 结构域的抗凝血因子 VIII 抑制剂同种抗体与猪凝血因子 VIII 的结合能力较差。
Int J Hematol. 1997 Feb;65(2):151-8. doi: 10.1016/s0925-5710(96)00555-5.
4
Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.利用人/猪杂交因子VIII分子绘制因子VIII抑制剂表位图谱。
Haematologica. 2000 Oct;85(10 Suppl):26-8; discussion 28-30.
5
Elimination of a major inhibitor epitope in factor VIII.消除凝血因子VIII中的一个主要抑制表位。
J Biol Chem. 1994 Mar 25;269(12):8639-41.
6
Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.与猪源同源物相比,人凝血因子VIII促凝活性降低的结构基础。
J Biol Chem. 1991 Jul 5;266(19):12481-6.
7
Antigenicity of putative phospholipid membrane-binding residues in factor VIII.凝血因子VIII中假定的磷脂膜结合残基的抗原性。
Blood. 2001 Jan 1;97(1):169-74. doi: 10.1182/blood.v97.1.169.
8
In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.基于计算机计算的 FVIII 衍生肽与 HLA Ⅱ类等位基因的亲和力可预测 F8 基因突变的血友病 A 患者产生抑制剂的情况。
Haemophilia. 2014 Mar;20(2):176-84. doi: 10.1111/hae.12276. Epub 2013 Oct 14.
9
The canine factor VIII cDNA and 5' flanking sequence.
Thromb Haemost. 1998 Feb;79(2):317-22.
10
Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.基于扫描透射电子显微镜(STEM)图像和STEM质量分析的猪源因子VIII和因子VIIIa分子结构模型
J Clin Invest. 1990 Jun;85(6):1983-90. doi: 10.1172/JCI114662.

引用本文的文献

1
Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.重组猪凝血因子VIII可在体外纠正先天性血友病A及伴有抑制剂患者血浆中的凝血酶生成。
Res Pract Thromb Haemost. 2022 Jun 19;6(4):e12731. doi: 10.1002/rth2.12731. eCollection 2022 May.
2
Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review.重组猪源凝血因子VIII治疗获得性血友病A:两例患者的经验及文献综述
Res Pract Thromb Haemost. 2022 Mar 27;6(2):e12688. doi: 10.1002/rth2.12688. eCollection 2022 Feb.
3
Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies.
VIII 因子单点 N-糖基化的去除改变了特异性单克隆抗体的结合。
J Thromb Haemost. 2022 Mar;20(3):574-588. doi: 10.1111/jth.15616. Epub 2021 Dec 17.
4
Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.猪重组因子 VIII:应对抗因子 VIII 抗体的另一种手段。
Blood Transfus. 2017 Jul;15(4):365-368. doi: 10.2450/2016.0030-16. Epub 2016 Jul 25.
5
Borrowing (once again) from the animal kingdom.(再一次)借鉴动物王国。
Blood Transfus. 2017 Jul;15(4):294-295. doi: 10.2450/2016.0104-16. Epub 2016 Jul 25.
6
and Model Systems for Hemophilia A Gene Therapy.以及A型血友病基因治疗的模型系统。
J Genet Syndr Gene Ther. 2013 Jan 17;Suppl 1. doi: 10.4172/2157-7412.S1-014.
7
Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.拓展针对因VIII因子抑制剂而变得复杂的血友病治疗的直系同源基因方法。
J Thromb Haemost. 2015 Jan;13(1):72-81. doi: 10.1111/jth.12755. Epub 2014 Nov 11.
8
Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.恒河猴和狒狒会因猪的内皮细胞或胰岛而产生凝血因子 VIII 抑制剂。
Xenotransplantation. 2014 Jul-Aug;21(4):341-52. doi: 10.1111/xen.12100. Epub 2014 May 8.
9
High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance.利用表面等离子体共振分析点突变体对因子 VIII C2 结构域表位的高分辨率作图。
Blood. 2014 Apr 24;123(17):2732-9. doi: 10.1182/blood-2013-09-527275. Epub 2014 Mar 3.
10
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.一种针对因子 IXa 和 X 的双特异性抗体可恢复血友病 A 模型中的因子 VIII 止血活性。
Nat Med. 2012 Oct;18(10):1570-4. doi: 10.1038/nm.2942. Epub 2012 Sep 30.